NORTH AMERICA BIOCHIPS MARKET 2019-2027


MARKET OUTLOOK
The North America biochips market is projected to develop at a CAGR of 19.57% during the forecasted period of 2019-2027. The technological development in the market and the increasing healthcare expenditure is elevating the biochips market in the North American region.
The biochips market report is studied in three major sections type, end-users, and substrate material. The United States and Canada are the major economies contributing to the North American biochips market. The rising market demand for precision medicines and the increasing healthcare expenditure is expected to rise the growth of the biochips market in the region. The rising application of biochips in different areas and the advancement in biochip technology are the key opportunities for the biochips market in the region. 
COMPETITIVE OUTLOOK 
The major competitors in the biochips market include Thermo Fisher Scientific Inc., Merck Gmbh, Illumina Inc., Origene Technologies Inc., Cybrdi Inc., Biochain Institute Inc., Fluidigm Corporation, Agilent Technology Inc., Bio-Rad Laboratories Inc., Imgenex, Perkinelmer Inc., Samsung Electronics Inc., Gamida For Life Group., Cepheid Inc., and Biomerieux Sa.
TABLE OF CONTENT
1. BIOCHIPS MARKET - SUMMARY 
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.3. EVOLUTION & TRANSITION OF BIOCHIPS 
2.4. PORTER'S FIVE FORCE ANALYSIS
2.5. MARKET ATTRACTIVENESS MATRIX 
2.6. INDUSTRY COMPONENTS
2.7. REGULATORY FRAMEWORK
2.8. VENDOR SCORECARD
2.9. KEY IMPACT ANALYSIS 
2.10. MARKET OPPORTUNITY INSIGHTS
2.11. INDUSTRY PLAYER POSITIONING
2.12. KEY MARKET STRATEGIES 
2.13. MARKET DRIVERS
2.13.1. GROWTH IN PERSONALIZED MEDICINES
2.13.2. RISING INCIDENCES & TREATMENT OF CANCER 
2.13.3. CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE
2.13.4. INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D
2.14. MARKET RESTRAINTS
2.14.1. INEQUALITY IN HEALTHCARE ACCESS
2.14.2. INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS
2.14.3. COMPLEXITY OF BIOLOGICAL SYSTEMS
2.15. MARKET OPPORTUNITIES
2.15.1. DEVELOPMENTS IN BIOCHIPS TECHNOLOGY
2.15.2. WIDENING APPLICATION AREAS OF BIOCHIPS 
2.16. MARKET CHALLENGES
2.16.1. AVAILABILITY OF SUBSTITUTE TECHNOLOGIES
2.16.2. UNCLEAR REGULATORY GUIDELINES
2.16.3. COST CONSTRAINTS
3. BIOCHIPS INDUSTRY OUTLOOK - BY TYPE
3.1. DNA CHIPS
3.1.1. AGRICULTURAL BIOTECHNOLOGY
3.1.2. CANCER DIAGNOSTICS & TREATMENT
3.1.3. DRUG DISCOVERY
3.1.4. GENE EXPRESSION
3.1.5. GENOMICS
3.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
3.1.7. OTHER DNA CHIPS
3.2. LAB ON A CHIP
3.2.1. CLINICAL DIAGNOSTICS
3.2.2. DRUG DISCOVERY
3.2.3. GENOMICS
3.2.4. POINT OF CARE & IN VITRO DIAGNOSIS
3.2.5. PROTEOMICS
3.2.6. OTHER LAB ON A CHIP
3.3. PROTEIN CHIPS
3.3.1. DIAGNOSTICS
3.3.2. DRUG DISCOVERY
3.3.3. EXPRESSION PROFILING
3.3.4. HIGH THROUGHPUT SCREENING
3.3.5. PROTEOMICS
3.3.6. OTHER PROTEIN CHIPS
3.4. OTHER CHIPS
3.4.1. CELL ARRAYS
3.4.2. TISSUE ARRAYS
4. BIOCHIPS INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL
4.1. GLASS
4.2. POLYMERS
4.3. SILICON
4.4. OTHER SUBSTRATE MATERIALS
5. BIOCHIPS INDUSTRY OUTLOOK - BY END USER
5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
5.2. HOSPITALS AND DIAGNOSTICS CENTERS
5.3. ACADEMIC AND RESEARCH INSTITUTE
6. BIOCHIPS INDUSTRY – NORTH AMERICA
6.1. UNITED STATES
6.2. CANADA
7. COMPETITIVE LANDSCAPE
7.1. AGILENT TECHNOLOGY INC.
7.2. BIOCHAIN INSTITUTE INC.
7.3. BIOMERIEUX SA
7.4. BIO-RAD LABORATORIES INC.
7.5. CEPHEID INC.
7.6. CYBRDI INC.
7.7. FLUIDIGM CORPORATION
7.8. GAMIDA FOR LIFE GROUP
7.9. ILLUMINA INC.
7.10. IMGENEX
7.11. MERCK GMBH
7.12. ORIGENE TECHNOLOGIES INC.
7.13. PERKINELMER INC.
7.14. SAMSUNG ELECTRONICS INC.
7.15. THERMO FISHER SCIENTIFIC INC.
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE 
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST  
TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET 
TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET 
TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET
TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET
TABLE 5. ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN THE UNITED STATES IN 2017 
TABLE 6. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017 
TABLE 7. ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF THE UNITED STATES, 2013-2015 (IN $ MILLIONS) 
TABLE 8. ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF THE UNITED STATES, 2013-2015 (IN $ MILLIONS)
TABLE 9. NORTH AMERICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 10. NORTH AMERICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION) 
TABLE 11. NORTH AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 12. NORTH AMERICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)




FIGURE LIST
FIGURE 1. NORTH AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET
FIGURE 3. KEY IMPACT ANALYSIS
FIGURE 4. TIMELINE OF BIOCHIPS
FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018
FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018 
FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET 
FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%)
FIGURE 9. UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP) 
FIGURE 10. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE 
FIGURE 11. NORTH AMERICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION) 
FIGURE 12. NORTH AMERICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
FIGURE 13. NORTH AMERICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
FIGURE 14. NORTH AMERICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) 
FIGURE 15. NORTH AMERICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION) 
FIGURE 16. NORTH AMERICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) 
FIGURE 17. NORTH AMERICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION) 
FIGURE 18. NORTH AMERICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) 
FIGURE 19. NORTH AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION) 
FIGURE 20. NORTH AMERICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 21. NORTH AMERICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 22. NORTH AMERICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 23. NORTH AMERICA LAB ON A CHIP MARKET, BY POINT OF CARE (POC) & IN VITRO DIAGNOSIS (IVS), 2019-2027 (IN $ MILLION) 
FIGURE 24. NORTH AMERICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 25. NORTH AMERICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 26. NORTH AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 27. NORTH AMERICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 28. NORTH AMERICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 29. NORTH AMERICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
FIGURE 30. NORTH AMERICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
FIGURE 31. NORTH AMERICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 32. NORTH AMERICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 33. NORTH AMERICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 34. NORTH AMERICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 35. NORTH AMERICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 36. NORTH AMERICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS) 
FIGURE 37. NORTH AMERICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
FIGURE 38. NORTH AMERICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
FIGURE 39. NORTH AMERICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
FIGURE 40. NORTH AMERICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)
FIGURE 41. NORTH AMERICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)
FIGURE 42. NORTH AMERICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
FIGURE 43. NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %) 
FIGURE 44. UNITED STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 45. CANADA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

TABLE LIST TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET TABLE 5. ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN THE UNITED STATES IN 2017 TABLE 6. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017 TABLE 7. ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF THE UNITED STATES, 2013-2015 (IN $ MILLIONS) TABLE 8. ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF THE UNITED STATES, 2013-2015 (IN $ MILLIONS) TABLE 9. NORTH AMERICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION) TABLE 10. NORTH AMERICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION) TABLE 11. NORTH AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION) TABLE 12. NORTH AMERICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION) FIGURE LIST FIGURE 1. NORTH AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET FIGURE 3. KEY IMPACT ANALYSIS FIGURE 4. TIMELINE OF BIOCHIPS FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018 FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018 FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%) FIGURE 9. UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP) FIGURE 10. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE FIGURE 11. NORTH AMERICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION) FIGURE 12. NORTH AMERICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION) FIGURE 13. NORTH AMERICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION) FIGURE 14. NORTH AMERICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 15. NORTH AMERICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION) FIGURE 16. NORTH AMERICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) FIGURE 17. NORTH AMERICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION) FIGURE 18. NORTH AMERICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) FIGURE 19. NORTH AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION) FIGURE 20. NORTH AMERICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION) FIGURE 21. NORTH AMERICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 22. NORTH AMERICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) FIGURE 23. NORTH AMERICA LAB ON A CHIP MARKET, BY POINT OF CARE (POC) & IN VITRO DIAGNOSIS (IVS), 2019-2027 (IN $ MILLION) FIGURE 24. NORTH AMERICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) FIGURE 25. NORTH AMERICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION) FIGURE 26. NORTH AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION) FIGURE 27. NORTH AMERICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION) FIGURE 28. NORTH AMERICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 29. NORTH AMERICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION) FIGURE 30. NORTH AMERICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION) FIGURE 31. NORTH AMERICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) FIGURE 32. NORTH AMERICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION) FIGURE 33. NORTH AMERICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) FIGURE 34. NORTH AMERICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION) FIGURE 35. NORTH AMERICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION) FIGURE 36. NORTH AMERICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS) FIGURE 37. NORTH AMERICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS) FIGURE 38. NORTH AMERICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS) FIGURE 39. NORTH AMERICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS) FIGURE 40. NORTH AMERICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS) FIGURE 41. NORTH AMERICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS) FIGURE 42. NORTH AMERICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS) FIGURE 43. NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %) FIGURE 44. UNITED STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 45. CANADA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Biotechnology Reports

North America Creatinine Measurement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Kits, Reagents); Type (Enzymatic Method, Jaffe's Kinetic Method); Sample Type (Blood or Serum, Urine); End-User (Hospitals, Diagnostic Laboratories, Others), and Country

The North American Creatinine Measurement Market is expected to reach US$ 269.75 million in 2027 from US$ 148.79 million in 2019. The market is estimated to grow with a CAGR of 7.8% from 2020-2027. The growth of the creatinine measurement market is a...

Europe Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

Europe, the Biodefense Market, is anticipated to reach US$ 2,516.91 Mn in 2027 from US$ 1,286.58 Mn in 2019. The market is projected to grow with a CAGR of 8.8% from 2020-2027. The Biodefense Market is growing primarily due to the presence of favorab...

Asia Pacific Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

Asia Pacific, the Biodefense Market, is anticipated to reach US$ 1,520.67 Mn in 2027 from US$ 723.70 Mn in 2019. The market is projected to grow with a CAGR of 9.8% from 2020-2027. The Biodefense Market is growing primarily due to the presence of fav...

North America Biodefense Market to 2027 - Regional Analysis and Forecasts by North America Biodefense Market to 2027 - Regional Analysis and Forecasts by Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others); and Country

The North American biodefense market is estimated to reach US$ 3,357.83 Mn by 2027 from US$ 1,569.29 Mn in 2019; it is projected to grow at a CAGR of 10.1% from 2019 to 2027. The growth of the biodefense market is primarily ascribed to the presence o...

Other Reports by Triton Market Research

GLOBAL RECYCLED GLASS MARKET 2020-2028

MARKET OUTLOOK According to Triton, the global recycled glass market is expected to display a positive market trend over the forecast years 2020-2028, exhibiting a CAGR of 6.02% (by revenue) and 6.25% (by volume). Glass has several advantageous prope...

GLOBAL PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per an analysis by the Triton Market Research on the global PP nonwoven market, it is estimated that the industry would show growth at a CAGR of 7.05% in the period 2020-2028. PP nonwoven material is used in the production of diaper...

NORTH AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report on the North American PP nonwoven market depicts that the market is likely to show growth at a CAGR of 6.87% in the forecast period between 2020 and 2028. The United States and Canada comprises the North...

MIDDLE EAST AND AFRICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per a Triton Market Research report, the PP nonwoven market in the Middle East and Africa is set to accelerate at a CAGR of 8.51% during the forecast period 2020-2028. Saudi Arabia, Turkey, the United Arab Emirates and the Rest of t...

LATIN AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report illustrates that the Latin American PP nonwoven market would exhibit a CAGR of 7.28% during the estimated period 2020-2028. Brazil, Mexico and the Rest of Latin America together form the PP nonwoven mark...

Publisher: Triton Market Research